← Leaderboards
Lim Andrew Lee
Integrated Micro-Chromatography Systems, Inc.
$5,650,230
Attributed
$5,650,230
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.6M · FY2020–25$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,650,230 · 3
By mechanism
R42$2,914,928 · 2
R44$2,735,302 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Communities”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$274,807,335
- Chanza Baytop · Westat, Inc.$271,217,917
- Valerie Koch · University Corporation For Atmospheric Res$247,762,266
- Joel A Lipkin · Four Points Technology, Llc$178,737,225
- John E West · University Of Texas At Austin$130,233,001
- Leonard Freedman · Leidos Biomedical Research, Inc.$98,171,500
Research focus
CommunitiesGlycosyltransferaseAnimalsComplexGlycosylationEnzymesDiagnosticCostBiologicalProductionReactionPriceOligosaccharidesPropertyPolysaccharidesGlycoproteinsSugarFutureReagentCommercializationMalignant NeoplasmsMonosaccharidesPlayFermentation
Grant awards (9)
Chemoenzymatic methods and reagents to access affordable (iso)globo- and(neo)lacto-glycosphingolipids$315,000
R42 · FY2025 · GM · contact PI
Affordable sialoglycans and associated reagents for expanded chemoenzymatic production$644,573
R42 · FY2024 · GM · contact PI
Affordable sialoglycans and associated reagents for expanded chemoenzymatic production$653,443
R42 · FY2023 · GM · contact PI
Developing chemoenzymatic strategies, enzymes, and kits for accessible and affordable gangliosides$882,086
R44 · FY2022 · GM · contact PI
Affordable sialoglycans and associated reagents for expanded chemoenzymatic production$661,912
R42 · FY2022 · GM · contact PI
Developing chemoenzymatic strategies, enzymes, and kits for accessible and affordable gangliosides$50,000
R44 · FY2022 · GM · contact PI
Developing chemoenzymatic strategies, enzymes, and kits for accessible and affordable gangliosides$903,216
R44 · FY2021 · GM · contact PI
Affordable sialoglycans and associated reagents for expanded chemoenzymatic production$640,000
R42 · FY2021 · GM · contact PI
Developing chemoenzymatic strategies, enzymes, and kits for accessible and affordable gangliosides$900,000
R44 · FY2020 · GM · contact PI